NCT00070291 2023-06-29Cyclosporine in Treating Patients With Recurrent or Refractory Angioimmunoblastic T-Cell LymphomaEastern Cooperative Oncology GroupPhase 2 Terminated4 enrolled 6 charts
NCT00513474 2017-05-25Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell TransplantMassachusetts General HospitalPhase 1 Completed46 enrolled 11 charts
NCT01177371 2010-08-09High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaCase Comprehensive Cancer CenterPhase 2 Completed13 enrolled